Cargando…
Neuroprotection in glaucoma-electrophysiology
Hypertensive glaucoma is defined as a group of diseases with progressive loss of the neuroretinal margin of the optic disc that causes characteristic degenerative optic neuropathy. The present study provided an updated summary of the physiology and pathology of neurotransmission in the visual path,...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086198/ https://www.ncbi.nlm.nih.gov/pubmed/32256717 http://dx.doi.org/10.3892/etm.2020.8509 |
_version_ | 1783509078151004160 |
---|---|
author | Lešták, Ján Fůs, Martin |
author_facet | Lešták, Ján Fůs, Martin |
author_sort | Lešták, Ján |
collection | PubMed |
description | Hypertensive glaucoma is defined as a group of diseases with progressive loss of the neuroretinal margin of the optic disc that causes characteristic degenerative optic neuropathy. The present study provided an updated summary of the physiology and pathology of neurotransmission in the visual path, with the focus on glaucoma. The results of positron emission tomography, functional magnetic resonance imaging and mainly electrophysiological methods demonstrated pathogenesis of nerve cell damage in the visual pathway. Based on these conclusions, neuroprotection in glaucoma was proposed. This consists mainly of the reduction of the intraocular pressure. It is followed by a decrease of glutamate in the synaptic cleft and blockade of its binding to the NMDA receptors. The supply of energy substrates to altered nerve cells is also indispensable. Therapy should be systemic due to impairment of the complete visual path. |
format | Online Article Text |
id | pubmed-7086198 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-70861982020-04-02 Neuroprotection in glaucoma-electrophysiology Lešták, Ján Fůs, Martin Exp Ther Med Review Hypertensive glaucoma is defined as a group of diseases with progressive loss of the neuroretinal margin of the optic disc that causes characteristic degenerative optic neuropathy. The present study provided an updated summary of the physiology and pathology of neurotransmission in the visual path, with the focus on glaucoma. The results of positron emission tomography, functional magnetic resonance imaging and mainly electrophysiological methods demonstrated pathogenesis of nerve cell damage in the visual pathway. Based on these conclusions, neuroprotection in glaucoma was proposed. This consists mainly of the reduction of the intraocular pressure. It is followed by a decrease of glutamate in the synaptic cleft and blockade of its binding to the NMDA receptors. The supply of energy substrates to altered nerve cells is also indispensable. Therapy should be systemic due to impairment of the complete visual path. D.A. Spandidos 2020-04 2020-02-10 /pmc/articles/PMC7086198/ /pubmed/32256717 http://dx.doi.org/10.3892/etm.2020.8509 Text en Copyright: © Lešták et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Review Lešták, Ján Fůs, Martin Neuroprotection in glaucoma-electrophysiology |
title | Neuroprotection in glaucoma-electrophysiology |
title_full | Neuroprotection in glaucoma-electrophysiology |
title_fullStr | Neuroprotection in glaucoma-electrophysiology |
title_full_unstemmed | Neuroprotection in glaucoma-electrophysiology |
title_short | Neuroprotection in glaucoma-electrophysiology |
title_sort | neuroprotection in glaucoma-electrophysiology |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086198/ https://www.ncbi.nlm.nih.gov/pubmed/32256717 http://dx.doi.org/10.3892/etm.2020.8509 |
work_keys_str_mv | AT lestakjan neuroprotectioninglaucomaelectrophysiology AT fusmartin neuroprotectioninglaucomaelectrophysiology |